From Tuberculosis Bedside to Bench: The Potential of RPS20, KIF13B and UBE2B Splicing as Biomarkers and the Regulatory Mechanism of UBE2B Splicing
Mengyuan Lyu(Sichuan University), Binwu Ying(Sichuan University), Zewang Gema(Ganzhou People's Hospital), Sheng Gong(Public Health Clinical Center of Chengdu), Weelic Chong(Thomas Jefferson University), Hongli Lai(Sichuan University), Wei Xu(Obstetrics and Gynecology Hospital of Fudan University), Yang Hai(Thomas Jefferson University Hospital), Jian Ding Zhou(Sichuan University), Jiongjiong Zeng(Ganzhou People's Hospital), Yi Chen(Chinese Academy of Sciences), Liyu Chen(Fujian Agriculture and Forestry University), Yili Wang, Lu Niu(Sun Yat-sen University), Yanbing Zhou(Sichuan University), Qinglan Wang(Fujian Medical University), Xiaojun Yao(Public Health Clinical Center of Chengdu), Chengdi Wang(Sichuan University)
Cited by 0
Related Papers
Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study
|Clinical Cancer Research|2018|355
SIRT5 Desuccinylates and Activates Pyruvate Kinase M2 to Block Macrophage IL-1β Production and to Prevent DSS-Induced Colitis in Mice
|Cell Reports|2017|340
Targeting Epigenetic Crosstalk as a Therapeutic Strategy for EZH2-Aberrant Solid Tumors
|Cell|2018|271
Recent advances in electrocatalytic ammonia synthesis
|CHINESE JOURNAL OF CATALYSIS (CHINESE VERSION)|2023|256